Tomohisa Nezu

Suggest Changes
Learn More
BACKGROUND The therapeutic efficacy of low-dose intravenous alteplase (0.6 mg/kg) for basilar artery occlusion (BAO) remains unknown. METHODS BAO patients enrolled from the Japanese multicenter(More)